Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech, Swift Biosciences to Jointly Market Library Prep Products in Europe and Asia Pacific

NEW YORK – Swift Biosciences and MGI Tech, a subsidiary of the BGI Group, said on Tuesday that they have signed an agreement to jointly market Swift's library preparation products in Europe and Asia Pacific.

Under the partnership, the companies will make Swift's library prep kits compatible with MGI's DNBSEQ sequencers, starting with the 2S Turbo DNA kit for whole-genome and targeted sequencing and the Rapid RNA and Methyl-Seq DNA Library kits.

"MGI is a valued partner and we will continue to grow the relationship," said Swift President and CEO Nathan Wood in a statement. "We have several exciting products launching this year and our R&D and manufacturing groups will be looking to enable the technology on the MGI platform as we continue our strategic worldwide growth."

MGI Chief Operating Officer Jiang Hui said in the statement that with this partnership, "MGI is demonstrating its commitment to continue opening its platform and bring more applications to our sequencing and grow our application community in order to support our customers."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more